EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Maternal supraphysiological hypercholesterolemia and its adverse impact on transgenerational cardiometabolic health: a literature review

Carolina Muñoz-Zamorano, Fabian Yap, Ling-Jun Li, Matthew W Kemp, Sebastián E Illanes, Andrea Leiva

Nutrition, Metabolism and Cardiovascular Diseases · 2026-05 · 36 (5) · 104540

DOI: 10.1016/j.numecd.2026.104540 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-05. Verfasst von Carolina Muñoz-Zamorano und 5 weiteren Autor:innen. Beteiligte Einrichtung: PhD Program in Chronic Diseases, Faculty of Medicine and Science, Universidad San Sebastián, Santiago, Chile. Hauptthemen laut MEDLINE: Hypercholesterolemia, Cardiovascular Diseases, Cholesterol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Universidad San Sebastián, National Commission for Scientific and Technological Research National Fund for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Among the risk factors leading to cardiovascular disease (CVD), hypercholesterolemia stands out as a key driver of vascular dysfunction and the development of atherosclerotic CVD. This review is aimed to highlight the emergent evidence showing that maternal supraphysiological hypercholesterolemia (MSPH) is a key risk factor for transgenerational CVD risk and to advocate for the development of strategies for the early prediction and prevention of MSPH. DATA SYNTHESIS: Increasing evidence suggests that an individual's lifetime CVD risk may be modified by in utero exposure. However, the contribution of maternal lipid levels to pregnancy has been neglected. In women, chronic hypercholesterolemia occurs during pregnancy, during which total cholesterol (TC) and low-density lipoprotein cholesterol (LDL) levels rise to meet fetal growth demands. Two patterns of increased pregnancy cholesterol levels have been described in the literature: i) those with maternal physiological hypercholesterolemia (MPH), characterized by increased TC levels at the end of gestation up to 280 mg/dl, and ii) those with MSPH, characterized by TC levels at the end of pregnancy above 280 mg/dl in combination with elevated LDL levels. This overlooked distinction is crucial considering the increased evidence linking MSPH to elevated cardiovascular risk in both mothers and offspring. CONCLUSION: Available data suggest that MSPH is associated with increased CVD risk in mothers in addition to fetal atherogenesis and increased lifetime risk of CVD in offspring. The implementation of early detection and interventions to mitigate MSPH could potentially improve acute and long-term health outcomes for both mothers and babies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaCardiovascular DiseasesCholesterolHumansFemalePregnancyBiomarkersRisk AssessmentDevelopmental Origins of Health and DiseaseCardiometabolic Risk FactorsAnimalsCholesterol, LDLAdultRisk FactorsPrognosis

Stichwörter der Autor:innen

Cardiovascular diseaseCholesterolDyslipidemiaLipoproteinsPregnancy

Substanzen

BiomarkersCholesterolCholesterol, LDL

Autor:innen und Institutionen

  • PhD Program in Chronic Diseases, Faculty of Medicine and Science, Universidad San Sebastián, Santiago, Chile.
  • Division of Medicine, KK Women's and Children's Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
  • Global Centre for Asian Women's Health (GloW), Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University…
  • Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Reproductive Biology Program, Center for Biomedical Research and Innovation, Universidad de los Ande…
  • PhD Program in Chronic Diseases, Faculty of Medicine and Science, Universidad San Sebastián, Santiago, Chile; School of Medical Technology, Faculty of Medicine and Science, Universidad San Sebastián, Santiago, Chile. El…

Förderung

  • Universidad San Sebastián
  • National Commission for Scientific and Technological Research National Fund for Scientific and Technological Development

Zitieren

APA

Muñoz-Zamorano, C., Yap, F., Li, L. J., Kemp, M. W., Illanes, S. E., & Leiva, A. (2026). Maternal supraphysiological hypercholesterolemia and its adverse impact on transgenerational cardiometabolic health: a literature review. Nutrition, Metabolism and Cardiovascular Diseases, 36(5), 104540. https://doi.org/10.1016/j.numecd.2026.104540

Vancouver

Muñoz-Zamorano C, Yap F, Li LJ, Kemp MW, Illanes SE, Leiva A. Maternal supraphysiological hypercholesterolemia and its adverse impact on transgenerational cardiometabolic health: a literature review. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(5):104540. doi:10.1016/j.numecd.2026.104540

BibTeX
@article{MuozZamorano2026,
  author = {Muñoz-Zamorano, Carolina and Yap, Fabian and Li, Ling-Jun and Kemp, Matthew W and Illanes, Sebastián E and Leiva, Andrea},
  title = {Maternal supraphysiological hypercholesterolemia and its adverse impact on transgenerational cardiometabolic health: a literature review},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  volume = {36},
  number = {5},
  pages = {104540},
  doi = {10.1016/j.numecd.2026.104540}
}
Kostenlos starten →